Literature DB >> 17605971

Oral cancer.

Deepak Kademani1.   

Abstract

Five percent of all tumors occur in the head and neck, and approximately half of those occur specifically in the oral cavity. Of the 615,000 new cases of head and neck [corrected] tumors reported worldwide in 2000, 300,000 were primary oral cavity squamous cell carcinomas. Recent data from the Surveillance, Epidemiology, and End Results Program suggest that 28,900 new cases of oral cancer will be identified and 7400 deaths attributed to oral cancer each year in the United States. The sixth leading cause of cancer-related mortality, oral cancer accounts for 1 death every hour in the United States. However, despite advances in screening tools, imaging technology, and access to primary care physicians, a considerable percentage of patients present with advanced-stage disease. Clinical signs and symptoms of head and neck tumors are often nonspecific and may be mistaken for other common ailments. Primary care physicians must be aware of the possibility of oral cancer, particularly the increasing incidence in young patients without traditional risk factors of alcohol and tobacco abuse. To improve survival, all patients should be routinely and vigilantly screened for oral mucosal lesions.

Entities:  

Mesh:

Year:  2007        PMID: 17605971     DOI: 10.4065/82.7.878

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  89 in total

1.  Prognostic value of miR-375 and miR-214-3p in early stage oral squamous cell carcinoma.

Authors:  Angela J Yoon; Shuang Wang; Jing Shen; Nicolas Robine; Elizabeth Philipone; Martin W Oster; Albert Nam; Regina M Santella
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

2.  Oral cancer awareness among undergraduate dental students in Iran.

Authors:  Graham R Ogden; Nima Mahboobi
Journal:  J Cancer Educ       Date:  2011-06       Impact factor: 2.037

3.  SOX4 expression is closely associated with differentiation and lymph node metastasis in oral squamous cell carcinoma.

Authors:  Masahiro Watanabe; Yuichi Ohnishi; Masahiro Wato; Akio Tanaka; Kenji Kakudo
Journal:  Med Mol Morphol       Date:  2013-09-13       Impact factor: 2.309

4.  Glutathione S-transferase M1 null genotype is associated with increased risk of oral cancer in East Asians: a meta-analysis.

Authors:  Yi Zhang; Qingqing Yu; Weixian Yu; Min Hu
Journal:  Tumour Biol       Date:  2013-06-26

5.  Impact of apigenin and kaempferol on human head and neck squamous cell carcinoma.

Authors:  Hollie I Swanson; Eun-Young Choi; W Brian Helton; C Gary Gairola; Joseph Valentino
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-11-05

6.  Elucidating the mechanism of miRNA-214 in the regulation of gingival carcinoma.

Authors:  Yu Gong; Hongli Yang; Xin Tian
Journal:  Exp Ther Med       Date:  2017-03-24       Impact factor: 2.447

7.  Expression of myelin and lymphocyte protein (MAL) in oral carcinogenesis.

Authors:  Samir Kumar Pal; Sunaki Noguchi; Gou Yamamoto; Atsushi Yamada; Tomohide Isobe; Shigeo Hayashi; Jun-Ichi Tanaka; Yoichi Tanaka; Ryutaro Kamijo; Gen-Yuki Yamane; Tetsuhiko Tachikawa
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

8.  Cyclin D1 overexpression enhances chemosensitivity to TPF chemotherapeutic agents via the caspase-3 pathway in oral cancer.

Authors:  Yong-Jie Hu; Wen-Wen Sun; Tong-Chao Zhao; Ying Liu; Dong-Wang Zhu; Li-Zhen Wang; Jiang Li; Chen-Ping Zhang; Zhi-Yuan Zhang; Lai-Ping Zhong
Journal:  Oncol Lett       Date:  2020-08-24       Impact factor: 2.967

9.  Epidemiology and cost analysis for patients with oral cancer in a university hospital in China.

Authors:  Sheng Han; Yan Chen; Xu Ge; Ming Zhang; Jinwei Wang; Qingbo Zhao; Jianjun He; Zhenghong Wang
Journal:  BMC Public Health       Date:  2010-04-16       Impact factor: 3.295

10.  Clinical significance of phosphatidyl inositol synthase overexpression in oral cancer.

Authors:  Jatinder Kaur; Meenakshi Sawhney; Siddartha Dattagupta; Nootan K Shukla; Anurag Srivastava; Ranju Ralhan
Journal:  BMC Cancer       Date:  2010-04-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.